Novel approach may prolong remission after T-cell immunotherapy for leukemia, lymphoma – Healio
|
Novel approach may prolong remission after T-cell immunotherapy for leukemia, lymphoma
Healio Researchers at Seattle Children's Hospital have launched a first-in-human trial to investigate whether infusions of T-cell antigen–presenting cells prolong the persistence of chimeric antigen receptor T-cell immunotherapy among children with relapsed … |
